Ankur Sethi, Emily Hiltner, Ashish Awasthi, Casey Panebianco, Tana LaPlaca, Nancy Rizzuto, Leonard Y Lee, Mark Russo
{"title":"Association Between Hospital Tiers and Cardiogenic Shock Mortality: Mitigating the Transfer Penalty Through a Regionalized Hub-and-Spoke Model.","authors":"Ankur Sethi, Emily Hiltner, Ashish Awasthi, Casey Panebianco, Tana LaPlaca, Nancy Rizzuto, Leonard Y Lee, Mark Russo","doi":"10.1161/CIRCHEARTFAILURE.126.014546","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cardiogenic shock remains associated with high short-term mortality despite contemporary advances in care. The association between institutional cardiac capability and outcomes-particularly among transferred patients and after accounting for clinical instability-remains incompletely defined. We sought to evaluate the association between hierarchical hospital cardiac capability and in-hospital mortality using a latent measure of acute physiological severity.</p><p><strong>Methods: </strong>Using the National Inpatient Sample (2016-2022), hospitals were classified into 5 hierarchical tiers ranging from non-percutaneous coronary intervention (tier 1) to heart transplant/durable left ventricular assist device (LVAD) centers (tier 5). Generalized structural equation modeling assessed the relationship between hospital tier and mortality. A latent Acute Severity construct-comprising cardiac arrest, acute kidney and liver injury, and mechanical ventilation-was incorporated to model the effects of clinical instability.</p><p><strong>Results: </strong>Among an estimated 1 177 180 cardiogenic shock hospitalizations, most occurred at cardiac surgical and transplant/LVAD centers. Crude mortality declined stepwise from non-percutaneous coronary intervention hospitals (64.4%) to transplant/LVAD centers (36.5%). After adjustment, a higher hospital tier was independently associated with lower mortality (tier 2 odds ratio [OR], 0.43 [95% CI, 0.38-0.48]; tier 3 OR, 0.37 [95% CI, 0.32-0.43]; tier 4 OR, 0.34 [95% CI, 0.30-0.38]; tier 5 OR, 0.36 [95% CI, 0.31-0.41]). Although transfer-in status was associated with increased mortality (OR 1.36 [95% CI, 1.30-1.43]), this association was attenuated at cardiac surgical and transplant/LVAD centers, consistent with mitigation of transfer-associated risk.</p><p><strong>Conclusions: </strong>Higher hospital cardiac capability is independently associated with lower mortality among patients with cardiogenic shock. Advanced centers are associated with mitigation of transfer-associated risk, supporting regionalized hub-and-spoke systems with early referral to high-capability centers.</p>","PeriodicalId":10196,"journal":{"name":"Circulation: Heart Failure","volume":"19 9","pages":"e014546"},"PeriodicalIF":8.3000,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Circulation: Heart Failure","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1161/CIRCHEARTFAILURE.126.014546","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/15 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Cardiogenic shock remains associated with high short-term mortality despite contemporary advances in care. The association between institutional cardiac capability and outcomes-particularly among transferred patients and after accounting for clinical instability-remains incompletely defined. We sought to evaluate the association between hierarchical hospital cardiac capability and in-hospital mortality using a latent measure of acute physiological severity.
Methods: Using the National Inpatient Sample (2016-2022), hospitals were classified into 5 hierarchical tiers ranging from non-percutaneous coronary intervention (tier 1) to heart transplant/durable left ventricular assist device (LVAD) centers (tier 5). Generalized structural equation modeling assessed the relationship between hospital tier and mortality. A latent Acute Severity construct-comprising cardiac arrest, acute kidney and liver injury, and mechanical ventilation-was incorporated to model the effects of clinical instability.
Results: Among an estimated 1 177 180 cardiogenic shock hospitalizations, most occurred at cardiac surgical and transplant/LVAD centers. Crude mortality declined stepwise from non-percutaneous coronary intervention hospitals (64.4%) to transplant/LVAD centers (36.5%). After adjustment, a higher hospital tier was independently associated with lower mortality (tier 2 odds ratio [OR], 0.43 [95% CI, 0.38-0.48]; tier 3 OR, 0.37 [95% CI, 0.32-0.43]; tier 4 OR, 0.34 [95% CI, 0.30-0.38]; tier 5 OR, 0.36 [95% CI, 0.31-0.41]). Although transfer-in status was associated with increased mortality (OR 1.36 [95% CI, 1.30-1.43]), this association was attenuated at cardiac surgical and transplant/LVAD centers, consistent with mitigation of transfer-associated risk.
Conclusions: Higher hospital cardiac capability is independently associated with lower mortality among patients with cardiogenic shock. Advanced centers are associated with mitigation of transfer-associated risk, supporting regionalized hub-and-spoke systems with early referral to high-capability centers.
期刊介绍:
Circulation: Heart Failure focuses on content related to heart failure, mechanical circulatory support, and heart transplant science and medicine. It considers studies conducted in humans or analyses of human data, as well as preclinical studies with direct clinical correlation or relevance. While primarily a clinical journal, it may publish novel basic and preclinical studies that significantly advance the field of heart failure.